|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 April 2021 |
|
Main ID: |
NCT03041428 |
|
Date of registration:
|
01/02/2017 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Ultra Protective Ventilation During Venoarterial Extracorporeal Membrane Oxygenation (UPV-ECMO)
UPV-ECMO |
|
Scientific title:
|
Effect of Ultraprotective Ventilation on the Lung Inflammatory Response in Patients With Acute Pulmonary Edema Treated With Venoarterial Extracorporeal Oxygenation |
|
Date of first enrolment:
|
February 1, 2017 |
|
Target sample size:
|
20 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT03041428 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Spain
| | | | | | | |
|
Contacts
|
|
Name:
|
Guillermo M Albaiceta |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
HUCA-FINBA, Universidad de Oviedo |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Cardiogenic pulmonary edema supported by venoarterial extracorporeal membrane
oxygenation.
- Invasive mechanical ventilatory support under sedation.
Exclusion Criteria:
- Immunosupresion.
- Hemodynamic instability refractory to mechanical support, conditioning an end-of-life
approach and terminal situation.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Cardiogenic Pulmonary Edema
|
|
Ventilator-Induced Lung Injury
|
|
Extracorporeal Circulation; Complications
|
|
Intervention(s)
|
|
Device: Ultraprotective ventilation
|
|
Primary Outcome(s)
|
|
Change in lung inflammatory mediators levels
[Time Frame: Baseline and 18 hours after the intervention]
|
|
Secondary ID(s)
|
|
FINBA_CritLab_1
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|